TCM

TCG Crossover Management Portfolio holdings

AUM $2.03B
1-Year Est. Return 373.29%
This Quarter Est. Return
1 Year Est. Return
+373.29%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.02B
AUM Growth
-$157M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
41
New
Increased
Reduced
Closed

Top Buys

1
+$44.9M
2
+$33.2M
3
+$32.7M
4
CDTX icon
Cidara Therapeutics
CDTX
+$26.1M
5
RAPT icon
RAPT Therapeutics
RAPT
+$19.8M

Top Sells

1
+$56.4M
2
+$7.62M
3
+$5.21M
4
ANTX icon
AN2 Therapeutics
ANTX
+$1.66M
5
ADVM
Adverum Biotechnologies
ADVM
+$989K

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
26
$14.6M 1.43%
3,858,000
27
$12.4M 1.21%
1,423,642
28
$12M 1.17%
650,000
29
$11.4M 1.11%
1,145,538
+137,380
30
$10.1M 0.99%
584,955
31
$8.71M 0.85%
550,000
-329,344
32
$8.39M 0.82%
1,796,482
-211,857
33
$7.9M 0.77%
2,676,580
34
$5.94M 0.58%
64,023
35
$3.72M 0.36%
266,667
36
$3.59M 0.35%
483,000
37
$692K 0.07%
316,195
38
$197K 0.02%
86,795
39
– –
-2,112,984
40
– –
-1,555,118
41
– –
-231,820
1
2